A positive response to immunosuppressive therapy characterized by the resolution of headaches, improvement or stabilization of cranial neuropathies and other neurological symptoms, reduction in ESR and CRP levels, and sometimes reversal of MRI abnormalities was observed in the majority of GPA-related PM cases [2]. The gene discussed is CRP; the disease is cranial nerve neuropathy.